This week's going-global focus centers on two threads: dense overseas clinical approvals for innovative drugs — two new drugs from CSPC PHARMA won US FDA recognition, and bispecific-antibody pipelines from BAO PHARMA and ANTENGENE received US and Australian regulatory approvals respectively — and accelerated Hong Kong financing, with SHEIN and Mech-Mind launching global offerings, LONGSYS passing its listing hearing, and LEADERDRIVE and Nazhen Technology advancing H-share listings. On the resources side, Mongolia's iron ore project has entered the construction phase and GUSHENGTANG is acquiring 100% of three Malaysian TCM institutions, as Chinese companies' global expansion evolves toward multidimensional coordination of technology, capital and channels.
NewTimeSpace News: On 28 August 2026, WEI YUAN HLDG (01343.HK) announced that WGC, its indirect wholly-owned subsidiary, has accepted the JTC consent letter to proceed with the redevelopment of the property in Singapore, raising the aggregate plot ratio from 0.85 and 0.90 to 1.40 on a combined basis, with completion required within two years from the date of the consent letter; the redevelopment may constitute a discloseable transaction under Chapter 14 of the Listing Rules.
NewTimeSpace News: Wai Chun Bio-Technology announced on August 25 that the Company has entered into a memorandum of understanding for strategic cooperation with multiple parties for the integrated AI digital‑infrastructure ecosystem project in Pahang Aviation City, Malaysia. The master‑planned site covers over 1,200 acres, with a planned IT load of 300 MW for the first‑phase development.
NewTimeSpace News: Jiaxin International Resources announced on August 24 that its subsidiary ZV entered into the Bakuta Mining Construction Contract with CCECC Kazakhstan Branch via public tender for the expansion project of No.1 tailings pond of the Bakuta Tungsten Mine. The initial contract price stands at approximately RMB 257 million (tax‑included), capped at roughly RMB 306 million.
NewTimeSpace News: On 24 August 2026, YANCOAL AUS (03668.HK) announced an increase in the annual cap under the Glencore framework coal sales agreement for the year ending 31 December 2026 from USD 350 million to USD 750 million, driven by higher spot purchase demand amid Middle East conflict turmoil and increased HVO spot sales, with H1 transaction volume of approximately USD 215 million.
NewTimeSpace News: On 23 August 2026, SUNSHINE OIL (02012.HK) announced that its wholly-owned subsidiary Sangxiang Petrochemical, holding a 40% stake, jointly established Deneng Zhisuan Artificial Intelligence Co., Ltd. in Beidaihe, Qinhuangdao with five JV partners to build a 6,000P computing power centre, supported by the Beidaihe government with a subsequent government-controlled equity stake.
This week's cross-border activities highlight biopharma and resources. Henlius partnered with Sandoz for up to 10 biosimilars globally, with combined milestone and upfront payments up to $314 million. Gaoshi Medical's corneal confocal microscope secured exclusive global distribution via HEIDELBERG. Sinopec Oilfield Service acquired a stake in a Mexican oilfield, while MMG's Las Bambas mine resumed operations after a suspension due to a fatal accident. On the financing front, Beijing Junzheng, ASR Microelectronics, Xingyu Auto, and Hunan Yuneng are advancing H-share listings to accelerate access to international capital.
NewTimeSpace News: On 19 August 2026, 5100 XIZANG (01115.HK) announced that its wholly-owned subsidiary entered into a distribution contract with Malaysia's Landmark Holding Sdn. Bhd., granting exclusive distribution rights in Malaysia and non-exclusive rights in Southeast Asian and Middle East export markets, with an initial three-year term renewable upon meeting performance targets, accelerating its overseas expansion.
NewTimeSpace News: On 17 August 2026, CHINAGOLDINTL (02099.HK) announced the engagement of SRK Consulting to conduct an independent feasibility study stage assessment of the proposed underground development project at the Changshanhao Gold Mine and prepare an NI 43-101 technical report, with block caving proposed for the transition from open-pit to underground mining and pre-development works already commenced; SRK's work will proceed in two stages of gap analysis and independent feasibility study.
NewTimeSpace News: On 17 August 2026, SHOUGANG CENT (00103.HK) announced the signing of a cooperation letter of intent with Beauty Realm Capital to jointly establish a joint venture in the tyre reinforcement materials sector and expand the global industrial rayon market; Beauty Realm Capital is the controlling shareholder of Cordenka, a globally leading industrial rayon producer, and a formal agreement is subject to further negotiation.
NewTimeSpace News: On 17 August 2026, SINOPEC SSC (01033.HK) announced that its wholly-owned subsidiary will acquire a 50% interest in Mexico DS and a 0.01% interest in the EBANO project for USD 4 million, indirectly holding a 55% interest in the EBANO project after completion, with follow-on investment of up to USD 212 million; the EBANO oilfield holds geological reserves of 4.92 billion barrels, and the acquisition does not constitute a connected transaction or major asset restructuring.
NewTimeSpace News: On 12 August 2026, WERIDE-W (00800.HK) reported its 2026 interim results: H1 revenue of RMB 345.9 million, up 73.3% year on year, with overseas revenue up 154.4%; gross margin improved from 30.6% to 36.6%, and EBITDA was negative RMB 667.0 million, narrowing 6.5% year on year. The global L4 fleet comprised approximately 3,400 vehicles, with operations spanning over 60 cities in 13 countries; the L2++/L3 solution WRD 3.0 shipped approximately 30,000 units in the quarter. Loss for the period was RMB 789.8 million, with no interim dividend declared.
NewTimeSpace News: On 12 August 2026, HANKING GOLD (03788.HK) announced the commencement of construction of the 5.5-million-tonne-per-annum processing plant for the Mt Bundy gold project, marking the project's official entry into the full construction phase; the plant will be the largest gold mill in the Northern Territory and, once operational, the second-largest gold mine by annual output in the Territory. The Company invested in Primary Gold in 2014 and fully acquired and delisted it in 2018, after which gold reserves increased by more than tenfold, with site levelling substantially completed.
NewTimeSpace News: The United Laboratories International announced on 11 August that UBT48128 Tablets, a Class 1 innovative drug independently developed by its wholly-owned subsidiary United Biotech, has been granted Investigational New Drug approval by the US FDA.
On August 5, Frost & Sullivan and LeadLeo released their 2026 AI Agent report, projecting market growth from RMB 2.6 tn (2025) to 20.1 tn (2030). YouLianCloud's Qilin Financial LLM, the sole finance-focused product, was named to the "Chinese Agents with the Greatest Global Development Potential" list.
NewTimeSpace News: On 10 August 2026, HANKING GOLD (03788.HK): Wholly-owned subsidiary Primary Gold awarded the two contracts for the 5.5 Mtpa processing plant of the Mt Bundy gold project to Delonix Solutions (EPC, fixed price of AUD 92.48 million) and CPC Engineering (EPCM, budget of AUD 28.5 million), with aggregate contract value of approximately AUD 120.98 million; the project targets dry plant commissioning by December 2027 and first gold production in Q1 2028.
